Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47


Therapeutic cancer vaccines: are we there yet?

Klebanoff CA, Acquavella N, Yu Z, Restifo NP.

Immunol Rev. 2011 Jan;239(1):27-44. doi: 10.1111/j.1600-065X.2010.00979.x. Review.


Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice.

Wang X, Berger C, Wong CW, Forman SJ, Riddell SR, Jensen MC.

Blood. 2011 Feb 10;117(6):1888-98. doi: 10.1182/blood-2010-10-310599.


Immunologic basis of vaccine vectors.

Liu MA.

Immunity. 2010 Oct 29;33(4):504-15. doi: 10.1016/j.immuni.2010.10.004. Review.


Memory T cells are enriched in lymph nodes of selectin-ligand-deficient mice.

Harp JR, Gilchrist MA, Onami TM.

J Immunol. 2010 Nov 15;185(10):5751-61. doi: 10.4049/jimmunol.1001878.


Naïve T cells re-distribute to the lungs of selectin ligand deficient mice.

Harp JR, Onami TM.

PLoS One. 2010 Jun 4;5(6):e10973. doi: 10.1371/journal.pone.0010973.


Advances in viral-vector systemic cytokine gene therapy against cancer.

Liu L, Wang S, Shan B, Sang M, Liu S, Wang G.

Vaccine. 2010 May 21;28(23):3883-7. doi: 10.1016/j.vaccine.2010.03.041. Review.


Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.

Paterson Y, Guirnalda PD, Wood LM.

Semin Immunol. 2010 Jun;22(3):183-9. doi: 10.1016/j.smim.2010.02.002. Review.


CD8 T cells activated in distinct lymphoid organs differentially express adhesion proteins and coexpress multiple chemokine receptors.

Ferguson AR, Engelhard VH.

J Immunol. 2010 Apr 15;184(8):4079-86. doi: 10.4049/jimmunol.0901903.


Listeria monocytogenes as a vector for anti-cancer therapies.

Tangney M, Gahan CG.

Curr Gene Ther. 2010 Feb;10(1):46-55. Review.


Memory CD8+ T cell differentiation.

Obar JJ, Lefrançois L.

Ann N Y Acad Sci. 2010 Jan;1183:251-66. doi: 10.1111/j.1749-6632.2009.05126.x. Review.


Homeostatic proliferation of naïve CD8+ T cells depends on CD62L/L-selectin-mediated homing to peripheral LN.

Schuster K, Gadiot J, Andreesen R, Mackensen A, Gajewski TF, Blank C.

Eur J Immunol. 2009 Nov;39(11):2981-90. doi: 10.1002/eji.200939330.


Fucosyltransferase IV and VII-directed selectin ligand function determines long-term survival in experimental tuberculosis.

Ehlers S, Schreiber T, Dunzendorfer A, Lowe JB, Hölscher C.

Immunobiology. 2009;214(8):674-82. doi: 10.1016/j.imbio.2008.12.009.


Differentiation of central memory CD8 T cells is independent of CD62L-mediated trafficking to lymph nodes.

Wirth TC, Badovinac VP, Zhao L, Dailey MO, Harty JT.

J Immunol. 2009 May 15;182(10):6195-206. doi: 10.4049/jimmunol.0803315.


Adoptive cell therapy for the treatment of patients with metastatic melanoma.

Rosenberg SA, Dudley ME.

Curr Opin Immunol. 2009 Apr;21(2):233-40. doi: 10.1016/j.coi.2009.03.002. Review.


Activated CD8 T cells redistribute to antigen-free lymph nodes and exhibit effector and memory characteristics.

Brinkman CC, Sheasley-O'Neill SL, Ferguson AR, Engelhard VH.

J Immunol. 2008 Aug 1;181(3):1814-24.


Stat6 signaling suppresses VLA-4 expression by CD8+ T cells and limits their ability to infiltrate tumor lesions in vivo.

Sasaki K, Zhao X, Pardee AD, Ueda R, Fujita M, Sehra S, Kaplan MH, Kane LP, Okada H, Storkus WJ.

J Immunol. 2008 Jul 1;181(1):104-8.


Cancer regression in patients after transfer of genetically engineered lymphocytes.

Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA.

Science. 2006 Oct 6;314(5796):126-9.


CD8+ T-cell memory in tumor immunology and immunotherapy.

Klebanoff CA, Gattinoni L, Restifo NP.

Immunol Rev. 2006 Jun;211:214-24. Review.


Abrogation of functional selectin-ligand expression reduces migration of pathogenic CD8+ T cells into heart.

Cai YH, Alvarez A, Alcaide P, Duramad P, Lim YC, Jarolim P, Lowe JB, Luscinskas FW, Lichtman AH.

J Immunol. 2006 Jun 1;176(11):6568-75.

Items per page

Supplemental Content

Support Center